Full 2023-24 season results of universal prophylaxis with nirsevimab in Galicia, Spain: the NIRSE-GAL study

Lancet Infect Dis. 2024 Dec 11:S1473-3099(24)00811-9. doi: 10.1016/S1473-3099(24)00811-9. Online ahead of print.
No abstract available

Publication types

  • Letter